Novel Insights into the Multiple Sclerosis Risk Gene <i>ANKRD55</i>
Aitzkoa Lopez de Lapuente(University of the Basque Country), Koen Vandenbroeck(Ikerbasque), Ana Feliú(Instituto Cajal), Francisco Carillo-Salinas(Instituto Cajal), Carmen Guaza(Instituto Cajal), Iraide Alloza(Ikerbasque), Míriam Mecha(Instituto Cajal), Ianire Astobiza(University of the Basque Country), José Ramón Martínez Riera(University of Alicante), Jorge Mena(University of the Basque Country), Nerea Ugidos-Damboriena(University of the Basque Country), Manuel Comabella(Universitat Autònoma de Barcelona), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya)
Cited by 23
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k